|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute kidney injury and post-reperfusion syndrome in liver transplantation显示文摘In the past decades liver transplantation(LT) has become the treatment of choice for patients with end stage liver disease(ESLD). The chronic shortage of cadaveric organs for transplantation led to the utilization of a greater number of marginal donors such as older donors or donors after circulatory death(DCD). The improved survival of transplanted patients has increased the frequency of long-term complications, in particular chronic kidney disease(CKD). Acute kidney injury(AKI) post-LT has been recently recognized as an important risk factor for the occurrence of denovo CKD in the long-term outcome. The onset of AKI post-LT is multifactorial, with pre-LT risk factors involved, including higher Model for End-stage Liver Disease score, more sever ESLD and pre-existing renal dysfunction, either with intra-operative conditions, in particular ischaemia reperfusion injury responsible for post-reperfusion syndrome(PRS) that can influence recipient's morbidity and mortality. Post-reperfusion syndrome-induced AKI is an important complication post-LT that characterizes kidney involvement caused by PRS with mechanisms not clearly understood and implication on graft and patient survival. Since preLT risk factors may influence intra-operative events responsible for PRS-induced AKI, we aim to consider all the relevant aspects involved in PRS-induced AKI in the setting of LT and to identify all studies that better clarified the specific mechanisms linking PRS and AKI. A Pub Med search was conducted using the terms liver transplantation AND acute kidney injury; liver transplantation AND post-reperfusion syndrome; acute kidney injury AND post-reperfusion syndrome; acute kidney injury AND DCD AND liver transplantation. Five hundred seventy four articles were retrieved on Pub Med search. Results were limited to title/abstract of English-language articles published between 2000 and 2015. Twenty-three studies were identified that specifically evaluated incidence, risk factors and outcome for patients developing PRS-induced AKI in liver transplantation. In order to identify intra-operative risk factors/mechanisms specifically involved in PRSinduced AKI, avoiding confounding factors, we have limited our study to 'acute kidney injury AND DCD AND liver transplantation'. Accordingly, three out of five studies were selected for our purpose. | Ilaria Umbro Francesca Tinti Irene Scalera Felicity Evison Bridget Gunson Adnan Sharif James Ferguson Paolo Muiesan Anna Paola Mitterhofer | 2016 | World Journal of Gastroenterology2016,22,42: | 16 |
| 2 | Different behaviour of BK-virus infection in liver transplantrecipients显示文摘Polyomavirus BK(BKV) infects up to 90% of the general population. After primary infection, occurring early during childhood, a state of non-replicative infection is established in the reno-urinary tract, without complications for immunocompetent hosts. In immunocompromised individuals, particularly transplanted patients, asymptomatic BKV viremia and/or viruria can be observed. Renal grafts may also be sources of infection as BKV prefers kidneys rather than other solid organs for transplantation such as the liver. The mechanism behind the higher incidence of BKV infection in kidney transplant patients, compared to liver or heart transplantation, is unclear and the prevalence of BKV infection in non-renal solid organ transplants has not been yet thoroughly investigated. We evaluated the prevalence of Polyomavirus BK infection among liver transplant recipients. A Pub Med search was conducted using the terms BKV infection AND liver transplant recipients; BKV AND non-renal solid organ transplant*; BKV infection AND immunosuppression; the search was limited to title/abstract and English-language articles published from 2000, to March 2015. Eleven relevant studies suggest that the prevalence of BKV viruria and/or viremia among liver transplant recipients is less than that reported in kidney or heart transplant recipients, except when chronic kidney disease(CKD) is present at the same time. Data also suggest that viruric and viremic patients have higher levels of serum creatinine than BKV negative patients. Moreover, no specific immunosuppressive drugs are associated with the onset of BKV nephropathy. The comorbidity of transplantation and CKD could play a major role in promoting BKV replication. | Ilaria Umbro Francesca Tinti Paolo Muiesan Anna Paola Mitterhofer | 2016 | World Journal of Gastroenterology2016,22,4: | 2 |
| 3 | Inflammation and immune response in acute aortic dissection显示文摘 | Flavia Del Porto Maria Proietta Luigi Tritapepe Fabio Miraldi Angela Koverech Patrizia Cardelli Fabio Tabacco Vincenzo De Santis Andrea Vecchione Anna Paola Mitterhofer Italo Nofroni Rachele Amodeo Massimo Trappolini Giuseppe Aliberti | 2010 | Annals of Medicine2010,,8: | 1 |
| 4 | Neuropsychiatric lupus syndromes:relationship with antiphospholipid antibodies显示文摘 | Afeltra A Garzia P Mitterhofer AP | 2003 | Neurology2003,61,1: | 1 |
| 5 | Polyomavirus BK replication in liver transplant candidates with normal renal function显示文摘 | Mitterhofer AP Tinti F Mordenti M | | 0,,04: | 1 |
| 6 | The 677C-T mutation in the methylenetetrahydrofolate reduetase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus 显示文摘 | Afeltra A Amoroso A Mitterhofer AP | 2002 | Seizure2002,11,4: | 1 |
| 7 | Antibodies to anionic phospholipids and anti-beta2-GPI:association with thrombosis and thrombocytopenia in systemic lupus erythematosus显示文摘 | Amoroso A Mitterhofer AP Del Porto F | 2003 | Hum Immunol2003,64,2: | 1 |
| 8 | Antibodies to anionic phospholipids and anti-beta2-GPI:association with thrombosis and thrombocytopenia in systemic lupus erythematosus 显示文摘 | Amoroso A Mitterhofer AP Del Porto F | 2003 | Hum Im- munol2003,64,2: | 1 |
| 9 | Long-term treatment of systemic lupus erythematosus with cyclosporin A显示文摘 | Caccavo D Lagana B Mitterhofer AP | 1997 | Arthritis Rheum1997,40,: | 1 |
| 10 | The 677C - T mutation in the methylenetetrahydrofolate reductase (MTH- FR) gene in epileptic patients affected by systemic lupus erythematosus显示文摘 | Afeltra A Amoroso A Mitterhofer AP | 2002 | Seizure2002,11,4: | 1 |